Meta-Analysis Probes Cancer Risk Concern for JAK Inhibitors

Although no increased cancer risk was seen vs methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than were tumor necrosis factor inhibitors in a meta-analysis.

Related Keywords

Basildon , Essex , United Kingdom , London , City Of , Manchester , British , Christopher Stovin , Anurag Bharadwaj , Essex Foundation , Princess Royal University Hospital , British Society For Rheumatology , King College Hospital , Drug Administration , British Society , College Hospital , Medscape Medical , Basildon Hospital , South Essex Foundation Trust , Rheumatoid Arthritis , A , Biologic Therapy , Cancer Risk , Cancer , Alignant Neoplasia , Arcinoma , Jak Stat , Ak Stat Signaling Pathway , Ak Stat Cytokine Receptors , Anti Tnf , Anti Tumor Necrosis Factor , Meta Analysis , Ankylosing Spondylitis , Psoriatic Arthritis , Arthritis , Oint Inflammation , Hospitals , Tumor , Dermatitis , Atopic Dermatitis , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying ,